Executive sells 9,366 BDX shares for $1.71M
Becton, Dickinson and Company reported an insider sale.
Rhea-AI Filing Summary
Becton, Dickinson and Company reported an insider sale. Christopher Delorefice sold 9,366 common shares on 02/18/2026 for $1,708,885.71. The filing lists multiple issuer-side equity award vesting and exercise events dated between 11/26/2024 and 11/26/2025.
Positive
- None.
Negative
- None.
Insights
Insider sale is disclosed and appears routine, tied to equity awards.
The record shows 9,366 shares sold by Christopher Delorefice on 02/18/2026 for $1,708,885.71. The filing also lists issuer-side vesting and option-exercise events dated 11/26/2024 through 11/26/2025.
These items align with scheduled equity compensation activity; subsequent filings would show whether further selling occurs.
Form 144 provides notice for an intended sale under Rule 144; details are transactional.
The submission names the seller, the sale date 02/18/2026, number of shares 9,366, and proceeds $1,708,885.71. It also lists multiple award vesting/exercise entries from 11/26/2024 to 11/26/2025.
Trade mechanics and any resale limits are not detailed here; future SEC reports may record completed transactions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the BDX filing disclose about insider Christopher Delorefice?
When were the equity awards and vesting events listed in the filing dated?
Does Form 144 confirm completion of the sale or only notice of intent?
AI-generated analysis. How Rhea-AI works. Not financial advice.